TNF and cancer: In this review we highlight recent data pointing out TNFα participation in the effectiveness of monoclonal antibodies (mAbs) targeting cancer cells, immune checkpoint inhibitors, and adoptive cell therapy (ACT), as well as its involvement in the adverse immune effects of immunotherapy.